United States securities and exchange commission logo
April 15, 2024
Dr. Raluca Dinu
Chief Executive Officer
QT Imaging Holdings, Inc.
3 Hamilton Landing, Suite 160
Novato, CA 94949
Re: QT Imaging
Holdings, Inc.
Registration
Statement on Form S-1
Filed April 2, 2024
File No. 333-278460
Dear Dr. Raluca Dinu:
We have conducted a limited review of your registration statement
and have the
following comment(s).
Please respond to this letter by amending your registration
statement and providing the
requested information. If you do not believe a comment applies to your
facts and circumstances
or do not believe an amendment is appropriate, please tell us why in
your response.
After reviewing any amendment to your registration statement and
the information you
provide in response to this letter, we may have additional comments.
Registration Statement on Form S-1 filed April 2, 2024
Cover Page
1. We note that you are
registering the issuance of 94,364 shares of Common Stock that are
issuable upon the
exercise of 94,364 Sponsor's Warrants and 5,375,000 shares of
Common Stock issuable
pursuant to the Yorkville Note for the Pre-Paid Advance. On
page 166, you note that
[i]n connection with the Closing, (i) the Sponsor elected to
partially convert (the
Conversion ) $943,640 in principal balance outstanding under the
Working Capital Note
into 94,364 shares of Common Stock and 94,364 Sponsor s
Warrants of the
Company." Likewise, you note on page 7 that "[a]s consideration for
a Pre-Paid Advance of
$10.0 million, in connection with the Closing, the Company issued
to Yorkville a
promissory note." It appears that the Sponsor's Warrants were issued on
March 4, 2024 and
became exercisable thirty days thereafter and that the Yorkville Note
was also issued on
March 4, 2024 and was immediately convertible. If an option becomes
exercisable within one
year, it is deemed to be immediately exercisable. Therefore, a
Dr. Raluca Dinu
FirstName
QT ImagingLastNameDr. Raluca Dinu
Holdings, Inc.
Comapany
April NameQT Imaging Holdings, Inc.
15, 2024
April 215, 2024 Page 2
Page
FirstName LastName
registration statement must be on file before the option is
exercisable for the entire
transaction to be a public offering. Given this, please tell us your
basis for registering the
offering of the shares underlying the Sponsor's Warrants and the
Yorkville Note for the
Pre-Paid Advance on a primary basis or revise the offering to only
register the resale of
such shares. Please refer to Securities Act Sections C&DI Questions
239.15, 139.09 and
103.04.
2. For each of the Private Placement Shares, Working Capital Shares,
Insider Shares,
Closing Shares and Sponsor's Warrants being registered for resale,
please disclose the
price that the selling securityholders paid for such shares or
warrants.
Risk Factors
Risks Related to Ownership of Company Common Stock and Other Securities
Future sales, or the perception of future sales, of Company Common Stock by us
or our existing
stockholders..., page 66
3. We note your statement that "[t]he sale of substantial amounts of
shares of Company
Common Stock in the public market, or the perception that such sales
could occur, could
harm the prevailing market price of shares of our Company Common
Stock." To illustrate
this risk, please disclose the purchase price of the securities being
registered for resale and
the percentage that these shares currently represent of the total
number of shares
outstanding. Also disclose that even though the current trading price
is significantly below
the SPAC IPO price, the private investors have an incentive to sell
because they will still
profit on sales because of the lower price that they purchased their
shares than the public
investors.
Management's Discussion and Analysis of Condition and Results of Operations of
QT Imaging
Overview, page 81
4. Please expand your discussion here to reflect the fact that this
offering involves the
potential sale of a substantial portion of your outstanding shares for
resale and discuss
how such sales could impact the market price of the company s common
stock. Your
discussion should highlight the fact that the shares being registered
for resale by the
selling stockholders collectively represent over 50% of your
outstanding shares and that
the Sponsor, a beneficial owner of over 33% of your outstanding
shares, will be able to
sell all of its shares for so long as the registration statement of
which this prospectus forms
a part is available for use.
General
5. We note that because the most recent balance sheet of QT Imaging, Inc.
included in the
Registration Statement is as of December 31, 2023, it does not reflect
the Closing of the
Business Combination with GigCapital5 that occurred on March 4, 2024.
We also note
that on March 22, 2024 you filed an Amendment No. 1 to a Current
Report on Form 8-
K/A containing unaudited pro forma condensed combined financial
information as of
Dr. Raluca Dinu
QT Imaging Holdings, Inc.
April 15, 2024
Page 3
December 31, 2023 and for the year then ended. Please include this pro
forma financial
information in your Registration Statement or explain to us why you are
not required to do
so.
6. Please revise your prospectus to disclose the price that each selling
securityholder paid for
the securities being registered for resale. Highlight any differences in
the current trading
price, the prices that the respective selling securityholders acquired
their shares and
warrants, and the price that the public securityholders acquired their
shares and
warrants. Please also disclose the potential profit the selling
securityholders will earn
based on the current trading price. Lastly, please include appropriate
risk factor disclosure.
We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.
Please contact Conlon Danberg at 202-551-4466 or Jessica Ansart at
202-551-4511 with
any other questions.
Sincerely,
FirstName LastNameDr. Raluca Dinu Division of
Corporation Finance
Office of
Industrial Applications and
Comapany NameQT Imaging Holdings, Inc.
Services
April 15, 2024 Page 3
cc: Jeffrey C. Selman, Esq.
FirstName LastName